Anti-cancer activities of ω-6 polyunsaturated fatty acids

Biomedical Journal

Volumn 37, Issue 3, 2014, Pages 112-119

  Xu, Yi ^a   Qian, Steven ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

anti cancer activity; apoptosis; cyclooxygenase catalyzed lipid peroxidation; dihomo linolenic acid; free radicals; 6 polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CARNITINE PALMITOYLTRANSFERASE I; CASPASE 3; CASPASE 9; CYCLIN A; CYCLIN D; CYTOCHROME C; DIHOMO GAMMA LINOLENIC ACID; DOCETAXEL; FAS ANTIGEN; GAMMA LINOLENIC ACID; HEXOKINASE; OMEGA 6 FATTY ACID; PACLITAXEL; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROTEIN P21; TRIACYLGLYCEROL; VINCRISTINE; ANTINEOPLASTIC AGENT; FREE RADICAL; PROSTAGLANDIN SYNTHASE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; HUMAN; IC 50; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; ANIMAL; METABOLISM; NEOPLASMS; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; FATTY ACIDS, OMEGA-6; FREE RADICALS; HUMANS; LIPID PEROXIDATION; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 84902463475     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.131378     Document Type: Article

References (83)

1. Chamras H, Ardashian A, Heber D, Glaspy JA. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 2002;13:711-6.
2. Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: Implications for cancer. Apoptosis 2009;14:135-52.
3. Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, et al. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 2009;45:2077-86.
4. D'Eliseo D, Manzi L, Merendino N, Velotti F. Docosahexaenoic acid inhibits invasion of human RT112 urinary bladder and PT45 pancreatic carcinoma cells via down-modulation of granzyme B expression. J Nutr Biochem 2012;23:452-7.
5. Kokura S, Nakagawa S, Hara T, Boku Y, Naito Y, Yoshida N, et al. Enhancement of lipid peroxidation and of the antitumor effect of hyperthermia upon combination with oral eicosapentaenoic acid. Cancer Lett 2002;185:139-44.
6. Siddiqui RA, Harvey KA, Xu Z, Bammerlin EM, Walker C, Altenburg JD. Docosahexaenoic acid: A natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. Biofactors 2011;37:399-412.
7. Cockbain AJ, Toogood GJ, Hull MA. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2012;61:135-49.
8. Wen B, Deutsch E, Opolon P, Auperin A, Frascognal V, Connault E, et al. n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance anti tumour effect of ionising radiation with inhibition of tumour angiogenesis. Br J Cancer 2003;89:1102-7.
9. Harris WS, Dayspring TD, Moran TJ. Omega-3 fatty acids and cardiovascular disease: New developments and applications. Postgrad Med 2013;125:100-13.
10. Haast RA, Kiliaan AJ. Impact of fatty acids on brain circulation, structure and function. Prostaglandins Leukot Essent Fatty Acids. 2014 [In Press].
11. Williams CD, Whitley BM, Hoyo C, Grant DJ, Iraggi JD, Newman KA, et al. A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res 2011;31:1-8.
12. Brown MD, Hart C, Gazi E, Gardner P, Lockyer N, Clarke N. Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on meta-static spread from prostate cancer. Br J Cancer 2010;102:403-13.
13. Thiebaut AC, Chajes V, Gerber M, Boutron-Ruault MC, Joulin V, Lenoir G, et al. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 2009;124:924-31.
14. Pot GK, Geelen A, van Heijningen EM, Siezen CL, van Kranen HJ, Kampman E. Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: An endoscopy-based case-control study. Int J Cancer 2008;123:1974-7.
15. Sauer LA, Blask DE, Dauchy RT. Dietary factors and growth and metabolism in experimental tumors. J Nutr Biochem 2007;18:637-49.
16. Kimura Y, Kono S, Toyomura K, Nagano J, Mizoue T, Moore MA, et al. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci 2007;98:590-7.
17. Li Y, Zhao H, Wang Y, Zheng H, Yu W, Chai H, et al. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol 2013;272:37-48.
18. Li S, Zhao X, Wu Z, Li Y, Zhu L, Cui B, et al. Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer. Fam Cancer 2013;12:755-65.
19. Pender-Cudlip MC, Krag KJ, Martini D, Yu J, Guidi A, Skinner SS, et al. Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue. Cancer Sci 2013;104:760-4.
20. Sakai M, Kakutani S, Horikawa C, Tokuda H, Kawashima H, Shibata H, et al. Arachidonic acid and cancer risk: A systematic review of observational studies. BMC Cancer 2012;12:606.
21. Yang P, Cartwright CA, Li J, Wen S, Prokhorova IN, Shureiqi I, et al. Arachidonic acid metabolism in human prostate cancer. Int J Oncol 2012;41:1495-503.
22. Amirian ES, Ittmann MM, Scheurer ME. Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Prostate 2011;71:1382-9.
23. Yang CM, Hsieh HL, Lee CW. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med J 2005;28:813-23.
24. Dommels YE, Haring MM, Keestra NG, Alink GM, van Bladeren PJ, van Ommen B. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE2 synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis 2003;24:385-92.
25. Fujiwara F, Todo S, Imashuku S. Antitumor effect of γ-linolenic acid on cultured human neuroblastoma cells. Prostaglandins Leukot Med 1986;23:311-20.
26. Leaver HA, Bell HS, Rizzo MT, Ironside JW, Gregor A, Wharton SB, et al. Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids 2002;66:19-29.
27. Colquhoun A, Schumacher RI. γ-Linolenic acid and eicosapentaenoic acid induce modifications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinosarcoma cells. Biochim Biophysica Acta 2001;1533:207-19.
28. Colquhoun A. Gamma-linolenic acid alters the composition of mitochondrial membrane subfractions, decreases outer mitochondrial membrane binding of hexokinase and alters carnitinepalmitoyltransferase I properties in the Walker 256 rat tumour. Biochim Biophys Acta 2002;1583:74-84.
29. Das UN. Cis-unsaturated fatty acids as potential anti-mutagenic, tumoricidal and anti-metastatic agents. Asia Pac J Pharmacol 1992;7:305-27.
30. Das UN. Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives. Curr Pharm Biotech 2006;7:457-66.
31. Begin ME, Das UN, Ells G, Horrobin DL. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med 1985;19:177-86.
32. Das UN. Essential fatty acids and their metabolites and cancer. Nutrition 1999;15:239-41.
33. Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett 1991;56:235-43.
34. Das UN. Gamma-linolenic acid, arachidonic acid and eicosapentaenoic acid as potential anti-cancer drugs. Nutrition 1990;6:429-34.
35. Sangeetha P, Das UN. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins Leukot Essen Fatty Acids 1995;53:287-99.
36. Begin ME, Ell G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986;77:1053-62.
37. Vartak S, McCaw R, Davis CS, Robbins ME, Spector AA. Gamma-linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to 'normal' rat astrocytes. Br J Cancer 1998;77:1612-20.
38. Das UN, Madhavi N. Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro. Lipids Health Dis 2011;10:159.
39. Ramchurren N, Karmali R. Effects of gamma-linolenic and dihomo-gamma-linolenic acids on 7, 12-dimethylbenz (alpha) anthracene-induced mammary tumors in rats. Prostaglandins Leukot Essent Fatty Acids 1995;53:95-101.
40. Yu Q, Purwaha P, Ni K, Sun C, Mallik S, Qian SY. Characterization of novel radicals from COX-catalyzed arachidonic acid peroxidation. Free Radic Biol Med 2009;47:568-76.
41. Xiao Y, Gu Y, Purwaha P, Ni K, Law B, Mallik S, et al. Characterization of free radicals formed from COX-catalyzed DGLA peroxidation. Free Radic Biol Med 2011;50:1163-70.
42. Gu Y, Xu Y, Law B, Qian SY. The first characterization of free radicals formed from cellular COX-catalyzed peroxidation. Free Radic Biol Med 2013;57:49-60.
43. Xu Y, Qi J, Yang XY, Wu E, Qian SY. Free radical derivatives formed from COX-catalyzed DGLA peroxidation can attenuate colon cancer cell growth and enhance 5-FU's cytotoxicity. Redox Biol 2014;2:610-8
44. Sagar PS, Das UN, Koratkar R, Ramesh G, Padma M, Kumar GS. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells: Relationship to free radicals, and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett 1992;63:189-98.
45. Tabolacci C, Lentini A, Provenzano B, Gismondi A, Rossi S, Beninati S. Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells. Melanoma Res 2010;20:273-9.
46. Mouradian M, Kikawa KD, Johnson ED, Beck KL, Pardini RS. Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced up regulation of lung and breast cancer cell growth. Prostaglandins Leukot Essent Fatty Acids 2013;90:105-15.
47. Welsch CW. Relationship between dietary fat and experimental mammary tumorigenesis: A review and critique. Cancer Res 1992;52:2040-8S.
48. Hudson EA, Beck SA, Tisdale MJ. Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem Pharmacol 1993;45:2189-94.
49. Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer 1997;29:114-9.
50. Horrobin DF, Ziboh VA. The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODE. Adv Exp Med Biol 1997;433:291-4.
51. Hillyard LA, Abraham S. Effect of dietary polyunsaturated fatty acids on growth of mammary adenocarcinomas in mice and rats. Cancer Res 1979;34:4430-7.
52. Carter CA, Millholland RJ, Shea W, Ip MM. Effect of the prostaglandin synthesis inhibitor indomethacin on 7, 12-dimethylbenz(a) anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res 1983;43:3559-62.
53. Abou-El-Ela SH, Prasse KW, Carroll R, Wade AE, Dharwadkar S, Bruce OR. Eicosanoid syntheses in 7, 12-dimethylbenz(a) anthracene-induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil. Lipids 1988;23:948-54.
54. Kitigawa H, Noguchi M. Comparative effects of piroxicam and esculetin on incidence, proliferation and cell kinetics of mammary carcinomas induced by 7, 12-dimethylbenz(a) anthracene on rats on high and low fat diets. Oncology 1995;51:407-10.
55. Wymann MP, Schneiter R. Lipid signaling in disease. Nat Rev Mol Cell Biol 2008;9:162-76.
56. Noguchi M, Rose DP, Earashi M, Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitor in breast carcinoma. Oncology 1995;52:265-71.
57. Kepler CR, Hirons KP, McNeill JJ, Tove SB. Intermediates and products of the biohydrogenation of linoleic acid by Butyrinvibriofibrisolvens. J Biol Chem 1966;241:1350-4.
58. Ewaschuk JB, Walker JW, Diaz H, Madsen KL. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 2006;136:1483-7.
59. Kelley NS, Hubbard NE, Erickson KL. Conjugated linoleic acid isomers and cancer. J Nutr 2007;137:2599-607.
60. Chujo H, Yamasaki M, Nou S, Koyanagi N, Tachibana H, Yamada K. Effect of conjugated linoleic acid isomers on growth factor-induced proliferation of human breast cancer cells. Cancer Lett 2003;202:81-7.
61. Tanmahasamut P, Liu J, Hendry LB, Sidell N. Conjugated linoleic acid blocks estrogen signaling in human breast cancer cells. J Nutr 2004;134:674-80.
62. De la Torre A, Debiton E, Durand D, Chardigny JM, Berdeaux O, Loreau O, et al. Conjugated linoleic acid isomers and their conjugated derivatives inhibit growth of human cancer cell lines. Anticancer Res 2005;25:3943-9.
63. Beppu F, Hosokawa M, Tanaka L, Kohno H, Tanaka T, Miyashita K. Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells. J Nutr Biochem 2006;17:830-6.
64. Palombo JD, Ganguly A, Bistrian BR, Menard MP. The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett 2002;177:163-72.
65. Kim EJ, Shin HK, Cho JS, Lee SK, Won MH, Kim JW, et al. Trans-10, cis-12 conjugated linoleic acid inhibits the G1-S cell cycle progression in DU145 human prostate carcinoma cells. J Med Food 2006;9:293-9.
66. Ochoa JJ, Farquharson AJ, Grant I, Moffat LE, Heys SD, Wahle KW. Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: Different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 2004;25:1185-91.
67. Liu JR, Chen BQ, Yang YM, Wang XL, Xue YB, Zheng YM, et al. Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid. World J Gastroenterol 2002;8:999-1004.
68. Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 1999;129:2135-42.
69. Banni S, Angioni E, Murru E, Carta G, Melis MP, Bauman D, et al. Vaccenic acid feeding increases tissue levels of conjugated linoleic acid and suppresses development of premalignant lesions in rat mammary gland. Nutr Cancer 2001;41:91-7.
70. Ip C, Dong Y, Ip MM, Banni S, Carta G, Angioni E, et al. Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer 2002;43:52-8.
71. Lavillonniere F, Chajes V, Martin JC, Sebedio JL, Lhuillery C, Bougnoux P. Dietary purified cis-9, trans-11 conjugated linoleic acid isomer has anticarcinogenic properties in chemically induced mammary tumors in rats. Nutr Cancer 2003;45:190-4.
72. Chen BQ, Xue YB, Liu JR, Yang YM, Zheng YM, Wang XL, et al. Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo(a) pyrene and chemopreventive mechanisms. World J Gastroenterol 2003;9:44-9.
73. Robinson KM, Botha JH. Effects of gamma-linolenic acid, dihomo-gamma-linolenic acid and ethanol on cultured human mammary carcinoma cells. Prostaglandins Leukot Med 1985;20:209-21.
74. Cho HJ, Kim EJ, Lim SS, Kim MK, Sung MK, Kim JS, et al. Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. J Nutr 2006;136:893-8.
75. Cho HJ, Kim WK, Jung JI, Kim EJ, Lim SS, Kwon DY, et al. Trans-10, cis-12, not cis-9, trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 2005;11:5142-50.
76. Yamasaki M, Chujo H, Koga Y, Oishi A, Rikimaru T, Shimada M, et al. Potent cytotoxic effect of the trans10, cis12 isomer of conjugated linoleic acid on rat hepatoma dRLh-84 cells. Cancer Lett 2002;188:171-80.
77. Song HJ, Sneddon AA, Heys SD, Wahle KW. Induction of apoptosis and inhibition of NF-kappaB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate 2006;66:839-46.
78. Fujiwara F, Todo S, Imashuku S. Fatty acid modification of cultured neuroblastoma cells by gamma linolenic acid relevant to its antitumor effect. Prostaglandins Leukot Med 1987;30:37-49.
79. Das UN. γ-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies. Med Sci Monit 2007;13:RA119-31.
80. Ikeguchi M, Maeta M, Kaibara N. Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosis. Int J Cancer 2000;88:474-8.
81. Xu Y, Gu Y, Qian SY. An advanced electron spin resonance (ESR) spin-trapping and LC/(ESR)/MS technique for the study of lipid peroxidation. Int J Mol Sci 2012;13:14648-66.
82. Qian SY, Xu Y, Gu Y. Combination of spin-trapping, LC/ESR and LC/MS technique in characterization of PUFA-derived free radicals in lipid peroxidation. Acta Biophys Sinica 2012;28:355-72.
83. Shaikh IA, Brown I, Wahle KW, Heys SD. Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids. Nutr Cancer 2010;62:284-96.